hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06329128, orgStudyIdInfo id: 2022/04, briefTitle: Evaluation of the Effectiveness of Manual Therapy in Patients With Knee Osteoarthritis, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-25, primaryCompletionDateStruct date: 2024-06-30, completionDateStruct date: 2024-09-30, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Hasan Kalyoncu University, class: OTHER, descriptionModule briefSummary: The aim of this study is to investigate the effects of three different applications (Manual therapy, electrotherapy and home program) on long-term pain, joint range of motion and, secondarily, the functional level of the knee., conditionsModule conditions: Osteoarthritis, Knee, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Participants were divided in two groups. One groups will get electrotherapy, exercise(home programme) and manuel therapy intervention. One group will be the control group. Control group will get electrotherapy and exercise (home programme)., primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Experimental: Study Group, interventions name: Active Comparator: Control Group, outcomesModule primaryOutcomes measure: The pain, primaryOutcomes measure: Functional status, primaryOutcomes measure: The quality of Life, primaryOutcomes measure: Lower extremity functional strength and balance test, primaryOutcomes measure: Functional mobility, eligibilityModule sex: ALL, minimumAge: 40 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Hasan Kalyoncu University, city: Gaziantep, state: Şahinbey, zip: 27100, country: Turkey, geoPoint lat: 37.05944, lon: 37.3825, hasResults: False
protocolSection identificationModule nctId: NCT06329115, orgStudyIdInfo id: 2024/23, briefTitle: Investigation of the Effectiveness of Regular Physical Activity in University Students, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-25, primaryCompletionDateStruct date: 2024-06-30, completionDateStruct date: 2024-06-30, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Hasan Kalyoncu University, class: OTHER, descriptionModule briefSummary: In our study, university students who coded the course from various faculties and departments within the scope of a university-wide free elective course, after regular physical activity; It was aimed to examine the effects on lifelong learning, physical activity, fatigue, sleepiness, depression, anxiety and stress levels, quality of life and walking distances and physiological expenditure indices., conditionsModule conditions: Regular Physical Activity, conditions: Exercise, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Participants will be included in an 8-week regular exercise program. Evaluations will be made before and after exercise., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Exercise training, outcomesModule primaryOutcomes measure: Lifelong learning, primaryOutcomes measure: Physical activity, primaryOutcomes measure: Fatique, primaryOutcomes measure: Daytime sleepiness, primaryOutcomes measure: Depression, anxiety and stress, primaryOutcomes measure: Quality of life measurement, primaryOutcomes measure: Physiological expenditure indices, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Hasan Kalyoncu University, city: Gaziantep, state: Şahinbey, zip: 27100, country: Turkey, geoPoint lat: 37.05944, lon: 37.3825, hasResults: False
protocolSection identificationModule nctId: NCT06329089, orgStudyIdInfo id: HCB/2023/0840, briefTitle: Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer, acronym: RENATA, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Hospital Clinic of Barcelona, class: OTHER, descriptionModule briefSummary: The goal of this observational study is to assess the effectiveness of sentinel lymph node biopsy as a treatment approach for patients with recurrent breast cancer on the same side as previous surgeries. The main questions it aims to answer are:* What is the rate of identification of the sentinel lymph node, and how does it vary among patients with different histories of axillary surgeries?* How can we describe and understand the drainage pathways, including those from the armpit on the same side as the cancer, the area near the breastbone, and the opposite armpit?Participants will undergo sentinel lymph node biopsy as part of their treatment for recurrent breast cancer. They will also receive standard treatments, including surgery and adjuvant therapies as recommended by their healthcare team., conditionsModule conditions: Recurrent Breast Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 97, type: ESTIMATED, armsInterventionsModule interventions name: Reoperative Sentinel Lymph Node Biopsy, outcomesModule primaryOutcomes measure: Re-Sentinel Lymph node harvesting rate, primaryOutcomes measure: Drainage pathways description, secondaryOutcomes measure: Complications rate, secondaryOutcomes measure: Axillary metastasis rate, secondaryOutcomes measure: Correlation Between Axillary and Internal Mammary Chain Infiltration, secondaryOutcomes measure: Quality of life in recurrent breast cancer, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 100 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Hospital Clínic de Barcelona, status: RECRUITING, city: Barcelona, zip: 08036, country: Spain, contacts name: Ines Torras Caral, role: CONTACT, phone: 93 227 54 00, phoneExt: 2499, email: itorras@clinic.cat, geoPoint lat: 41.38879, lon: 2.15899, hasResults: False
protocolSection identificationModule nctId: NCT06329076, orgStudyIdInfo id: BAM_lab_eyetracking_04, briefTitle: Losartan Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-05, primaryCompletionDateStruct date: 2025-06-01, completionDateStruct date: 2025-07-30, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: University of Electronic Science and Technology of China, class: OTHER, descriptionModule briefSummary: The main aim of the present study is to investigate the effects of orally administered losartan on the perception of time-to-collision of threatening and non-threatening stimuli by combining a validated looming fear eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design., conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: DOUBLE, maskingDescription: Randomized placebo-controlled double-blind between-subject design, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Losartan, interventions name: Placebo, outcomesModule primaryOutcomes measure: Ratio of judged-time-to-collision to actual-time-to-collision for threatening versus non-threatening stimuli after losartan administration, secondaryOutcomes measure: First saccade latency(ms) for threatening versus non-threatening stimuli after losartan administration, secondaryOutcomes measure: Fixation duration(ms) for threatening versus non-threatening stimuli after losartan administration, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Electronic Science and Technology of China, status: RECRUITING, city: Chengdu, state: Sichuan, country: China, contacts name: Weihua Zhao, Dr, role: CONTACT, phone: 86-28-61830811, email: zarazhao.uestc@outlook.com, geoPoint lat: 30.66667, lon: 104.06667, hasResults: False
protocolSection identificationModule nctId: NCT06329063, orgStudyIdInfo id: BAM_lab_eyetracking_03, briefTitle: Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-05, primaryCompletionDateStruct date: 2025-06-01, completionDateStruct date: 2025-07-30, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: University of Electronic Science and Technology of China, class: OTHER, descriptionModule briefSummary: The main aim of the present study is to investigate the effects of orally administered vasopressin (AVP) on the perception of time-to-collision of threatening and non-threatening stimuli by combining a validated looming fear eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design., conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: DOUBLE, maskingDescription: Randomized placebo-controlled double-blind between-subject design, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Vasopressin, interventions name: Placebo, outcomesModule primaryOutcomes measure: Ratio of judged-time-to-collision to actual-time-to-collision for threatening versus non-threatening stimuli after oral vasopressin administration, secondaryOutcomes measure: First saccade latency(ms) for threatening versus non-threatening stimuli after oral vasopressin administration, secondaryOutcomes measure: Fixation duration(ms) for threatening versus non-threatening stimuli after oral vasopressin administration, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Electronic Science and Technology of China, status: RECRUITING, city: Chendu, state: Sichuan, country: China, contacts name: Weihua Zhao, Dr, role: CONTACT, phone: 86-28-61830811, email: zarazhao.uestc@outlook.com, hasResults: False
protocolSection identificationModule nctId: NCT06329050, orgStudyIdInfo id: BAM_lab_eyetracking_02, briefTitle: The Effects of Losartan on Attention Control: An Eye-tracking Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-05, primaryCompletionDateStruct date: 2025-06-01, completionDateStruct date: 2025-07-30, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: University of Electronic Science and Technology of China, class: OTHER, descriptionModule briefSummary: The main aim of the present study is to investigate the effects of orally administered Losartan on bottom-up and top-down attentional control to socio-emotional stimuli by combining a validated saccade/antisaccade eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design., conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Losartan, interventions name: Placebo, outcomesModule primaryOutcomes measure: Saccade/antisaccade latency difference between social and non-social stimuli after losartan administration, primaryOutcomes measure: Error rate of saccade/antisaccade for social versus non-social stimuli after losartan administration, secondaryOutcomes measure: Saccade/antisaccade latency for different facial emotions after losartan administration, secondaryOutcomes measure: Error rate of saccade/antisaccade for different facial emotions after losartan administration, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Electronic Science and Technology of China, status: RECRUITING, city: Chengdu, state: Sichuan, zip: 611731, country: China, contacts name: Weihua Zhao, Dr, role: CONTACT, phone: 86-28-61830811, email: zarazhao.uestc@outlook.com, geoPoint lat: 30.66667, lon: 104.06667, hasResults: False
protocolSection identificationModule nctId: NCT06329037, orgStudyIdInfo id: BAM_lab_eye-tracking_01, briefTitle: The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-05, primaryCompletionDateStruct date: 2025-06-01, completionDateStruct date: 2025-07-30, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: University of Electronic Science and Technology of China, class: OTHER, descriptionModule briefSummary: The main aim of the present study is to investigate the effects of orally administered vasopressin (AVP) on bottom-up and top-down attentional control to socio-emotional stimuli by combining a validated saccade/antisaccade eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design., conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized placebo-controlled double-blind between-subject design, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Vasopressin, interventions name: Placebo, outcomesModule primaryOutcomes measure: Saccade/antisaccade latency difference between social and non-social stimuli after oral vasopressin administration, primaryOutcomes measure: Error rate of saccade/antisaccade for social versus non-social stimuli after oral vasopressin administration, secondaryOutcomes measure: Saccade/antisaccade latency for different facial emotions after oral vasopressin administration, secondaryOutcomes measure: Error rate of saccade/antisaccade for different facial emotions after oral vasopressin administration, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Electronic Science and Technology of China, status: RECRUITING, city: Chengdu, state: Sichuan, zip: 611731, country: China, contacts name: Weihua Zhao, Dr, role: CONTACT, phone: 86-28-61830811, email: zarazhao.uestc@outlook.com, geoPoint lat: 30.66667, lon: 104.06667, hasResults: False
protocolSection identificationModule nctId: NCT06329024, orgStudyIdInfo id: myofascial dysphagiapoststrok, briefTitle: The Impact of Myofascial Release Therapy on Dysphagia in Post-stroke Patients, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Copka Sonpashan, class: OTHER_GOV, descriptionModule briefSummary: The goal of this clinical trial is to explore Clinical Effect of Myofascial Release Therapy in Dysphagic Stroke Survivors. The main question it aims to answer is:• Can Myofascial Release Therapy improve swallowing function in Stroke Survivors? Patients will be randomly allocated into the control group or the experimental group, all under rehabilitation treatment, the experimental group will be given Myofascial Release Therapy. The study lasts 21 days for each patient. Researchers will compare the Functional Oral Intake Scale, Penetration-Aspiration Scale, Swallowing Quality of Life to see if the Myofascial Release Therapy can help improve the situation., conditionsModule conditions: Dysphagia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Rehabilitation treatment, interventions name: Myofascial Release Therapy, outcomesModule primaryOutcomes measure: Penetration-Aspiration Scale, secondaryOutcomes measure: Swallowing Quality of Life questionnaire, secondaryOutcomes measure: Patient health questionnaire-9, secondaryOutcomes measure: Functional Oral Intake Scale, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06329011, orgStudyIdInfo id: TDC+IOE, briefTitle: Combining Transcranial Direct Current Stimulation With Intermittent Oral to Esophageal Tube for Stroke-related Dysphagia, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Copka Sonpashan, class: OTHER_GOV, descriptionModule briefSummary: The study is a double-blind randomized controlled trial, lasting for 15 days for each participant. Patients with post-stroke dysphagia who receive treatment at the Rehabilitation Department are selected as the study subjects. The patients are randomly assigned to either the experimental group or the placebo group. All patients receive routine rehabilitation therapy and swallowing rehabilitation training, along with enteral nutrition support using Intermittent Oro-esophageal Tube. In addition to these interventions, patients in the experimental group receive transcranial direct current stimulation, while the instruments used for patients in the placebo group only illuminate an indicator light without any actual effect., conditionsModule conditions: Stroke, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Comprehensive rehabilitation therapy, interventions name: Intermittent Oro-esophageal Tube Feeding, interventions name: Transcranial direct current stimulation, interventions name: Placebo Transcranial direct current stimulation, outcomesModule primaryOutcomes measure: Penetration Aspiration Scale, secondaryOutcomes measure: Functional Oral Intake Scale, secondaryOutcomes measure: Swallowing Quality of Life Questionnaire, secondaryOutcomes measure: Patient Health Questionnaire-9, secondaryOutcomes measure: Body weight, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06328998, orgStudyIdInfo id: Intra-articular Injection, briefTitle: Intra-articular Injection Versus Normal Rehabilitation Therapy on Temporomandibular Joint Dysfunction, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Copka Sonpashan, class: OTHER_GOV, descriptionModule briefSummary: The goal of this clinical trial is to study about the clinical effect of Intra-articular Injection on Temporomandibular Joint DysfunctionThe main question it aims to answer is:• Can Intra-articular Injection help improve the Temporomandibular Joint Dysfunction Participants will be randomly assigned into the experimental group and the control group, all under comprehensive treatment. The experimental group will be given Intra-articular Injection additionally, The study lasts 15 days for each patient. Researchers will compare the assessments between the two groups to see if Intra-articular Injection can help improve the Temporomandibular Joint Dysfunction, conditionsModule conditions: Temporomandibular Joint Dysfunction, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Routine rehabilitation treatment, interventions name: Intra-articular Injection, interventions name: Lidocaine Hydrochloride, outcomesModule primaryOutcomes measure: Friction Index, secondaryOutcomes measure: The Visual Analog Scale, secondaryOutcomes measure: The maximum mouth opening limit, secondaryOutcomes measure: Mann Assessment of Swallowing Ability, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06328985, orgStudyIdInfo id: IOETraumatic Brain Injury, briefTitle: Intermittent Oro-esophageal Tube Feeding in Traumatic Brain Injury Patients, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Copka Sonpashan, class: OTHER_GOV, descriptionModule briefSummary: This was a multicenter randomized controlled study of 98 severe Traumatic Brain Injury patients with tracheostomy. Patients enrolled were divided randomly into the observation group with Intermittent Oro-esophageal Tube Feeding or the control group with Nasogastric tube feeding for enteral nutrition support, respectively. Nutritional status, complications, decannulation of tracheostomy tubes and level of consciousness on day 1 and day 28 were recorded and compared., conditionsModule conditions: Traumatic Brain Injury, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Rehabilitation therapy, interventions name: Intermittent Oro-esophageal Tube Feeding, interventions name: Nasogastric tube feeding, outcomesModule primaryOutcomes measure: Concentration of hemoglobin, primaryOutcomes measure: Concentration of albumin, primaryOutcomes measure: Concentration of prealbumin, primaryOutcomes measure: body mass index, secondaryOutcomes measure: Decannulation of tracheostomy tube-placement duration, secondaryOutcomes measure: Decannulation of tracheostomy tube-Successful removal, secondaryOutcomes measure: Level of consciousness, secondaryOutcomes measure: Feeding Amount, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False